Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest cancer detection Stories

2012-06-25 10:25:26

BREA, Calif., June 25, 2012 /PRNewswire/ -- Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5-times more specific in detecting prostate cancer[1] than PSA (prostate-specific antigen) in patients with PSA values in the 4-10 ng/mL range and is proven to reduce the number of prostate biopsies[2]. (Photo:...

2012-04-04 10:10:00

The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident breast cancers, according to a study in the April 4 issue of JAMA. "Annual ultrasound screening may detect small, node-negative breast cancers that are not seen on mammography. Magnetic resonance imaging may reveal additional breast cancers missed by both mammography and...

2012-03-27 02:26:47

NEWPORT NEWS, Va., March 27, 2012 /PRNewswire/ -- Dilon Diagnostics -- According to the results from a new multi-center patient registry, presented at the National Consortium of Breast Centers Annual Meeting on March 11th, 2012, Breast-Specific Gamma Imaging (BSGI) also known as Molecular Breast Imaging (MBI) improves breast cancer detection when added to mammography and ultrasound in the breast clinic. In this study, BSGI/MBI detected cancers in nearly 13% of patients with negative or...

2012-02-21 13:22:33

90 percent detection rate in clinical tests for multiple types of cancers A simple blood test is being developed by researchers at Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center in Beer-Sheva, Israel that may provide early detection of many types of cancer. Prof. Kapelushnik of BGU's Faculty of Health Sciences and his team developed a device that illuminates cancer cells with less than a teaspoon of blood. The test uses infrared light to detect miniscule...

2011-11-17 11:00:18

MammaCare technology sets standards for clinical breast exams MammaCare, a revolutionary tool that has set standards for teaching women and clinicians how to perform clinical breast exams, is training professionals around the country to detect lumps earlier and save lives. Widely-publicized statistics inform women about the importance of early detection of cancer. The Center for Disease Control reports that second only to skin cancer, breast cancer is the most common cancer among...

2011-11-07 08:00:00

Oncimmune (USA) LLC recognizes Lung Cancer Awareness Month through a unique public awareness campaign. Oncimmune will feature 30 lung cancer stories from survivors and loved ones impacted by lung cancer on the HelloHaveYouHeard.com blog. De Soto, KS (PRWEB) November 07, 2011 Oncimmune (USA) LLC, maker of EarlyCDT®-Lung, a simple blood test that aids physicians in the early detection of lung cancer, is promoting Lung Cancer Awareness Month (LCAM) through an educational blog series. The...

2011-10-20 11:00:00

BAD BIRNBACH, Germany, October 20, 2011 /PRNewswire/ -- The future of skin cancer diagnosis is connected Picture is available via epa european pressphoto agency and can be downloaded free of charge at: http://ots.de/OmvW2 At Medica 2011, FotoFinder presents the future of early skin cancer detection. In the center of attention is the fast diagnostic exchange between doctors using mobile communication technology. With handyscope for iPhone and the...

2011-08-26 15:42:57

An engineering researcher and a global health expert from Michigan State University are working on bringing a low-cost, hand-held device to nations with limited resources to help physicians detect and diagnose cancer. Syed Hashsham, a professor of civil and environmental engineering at MSU, is developing the Gene-Z device, which is operated using an iPod Touch or Android-based tablet and performs genetic analysis on microRNAs and other genetic markers. MicroRNAs are single-stranded...

2011-08-08 12:21:25

A new study supports the use of a DNA-based "biomarker" blood test as a complement to the prostate-specific antigen (PSA) test currently offered to screen men for prostate cancer. University of Cincinnati (UC) researchers report their findings online ahead of print in the British Journal of Cancer. Researchers conducted a meta-analysis of existing published data related to DNA methylation in bodily fluids. The goal was to evaluate a specific cancer biomarker"”known as GSTP1"”as a...

2011-07-25 00:00:28

Oncimmune, LLC announces the launch of a public awareness campaign designed to educated consumers about the importance of early lung cancer detection and the risk factors of lung cancer. De Soto, KS (PRWEB) July 25, 2011 Oncimmune® LLC, maker of EarlyCDTâ“ž¢-Lung, a simple blood test that aids physicians in the early detection of lung cancer, proudly announces the launch of a public awareness initiative designed to educate consumers about lung cancer...